Drugs / Fluzone Quadrivalent vaccine, No Preservative
Fluzone Quadrivalent vaccine, No Preservative
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02915302 | Sep 2016 → Mar 2017 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone Quadrivalent vaccine, No Preservative | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02915302 ↗ |
| Modality | Vaccine | “quadrivalent, split-virion, inactivated influenza vaccine (IIV4)” PMID 30395011 ↗ Mar 2019 |
| Route | Intramuscular | “intramuscularly” NCT02915302 ↗ |